According to the company, the rapid test developed in just six weeks can detect infection with the coronavirus SARS-CoV-2 in patients in less than two and a half hours - measured from the time the sample is taken to the time the result arrives. Bosch’s rapid test is one of the world’s first fully automated molecular diagnostic tests that can be used directly by all medical institutions. Additionally, it allows a single sample to be tested not just for COVID-19 but also for nine other respiratory diseases, including influenza A and B, simultaneously.
In various laboratory tests with SARS-CoV-2, the Bosch test delivered results with an accuracy of over 95 percent. The rapid test meets the quality standards of the World Health Organization and will available in Germany starting in April, with other markets in Europe and elsewhere to follow. Bosch’s rapid COVID-19 test is the result of collaboration between the company’s Bosch Healthcare Solutions subsidiary and the Northern Irish medical technology company Randox Laboratories Ltd..
Read the complete news item
The new Bosch rapid COVID-19 test (picture: Bosch)
